United States (USA) Intravenous (IV) Equipments Market Overview, 2028
The United States has one of the largest and most technologically advanced healthcare systems globally. The extensive network of hospitals, clinics, and healthcare facilities contributes to a substantial demand for IV equipment for various medical procedures and treatments. The prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, is relatively high in the United States. Many of these conditions require on-going treatment and management, often involving the use of IV equipment for medication administration and therapeutic interventions. The U.S. is a global leader in medical research and development. Continuous innovation in healthcare technologies, including IV equipment, is a result of substantial investment in research and collaboration between academic institutions, healthcare providers, and industry stakeholders. The regulatory environment in the U.S., governed by the Food and Drug Administration (FDA), ensures that IV equipment meets stringent safety and efficacy standards. The FDA approval process helps build confidence in the quality and reliability of IV products, making the U.S. market a preferred destination for both domestic and international manufacturers. On-going investments in healthcare infrastructure, including the adoption of electronic health records (EHRs) and integrated healthcare systems, create a conducive environment for the implementation of advanced IV technologies. This infrastructure supports seamless communication and coordination in patient care. Demographic factors, such as an aging population, contribute to the demand for healthcare services, including IV therapy. The aging demographic often requires treatments for chronic conditions, surgeries, and other medical interventions that involve the use of IV equipment.
According to the research report ""United States Intravenous (IV) Equipments Market Overview, 2028,"" published by Bonafide Research, the United States IV Equipments market was valued more than USD 3 Billion in 2022. The IV equipment market has seen a continuous influx of technological innovations. This includes the development of smart infusion pumps, which offer features such as dose error reduction systems, wireless connectivity for remote monitoring, and integration with electronic health records (EHRs). These advancements aim to enhance patient safety, reduce medication errors, and improve overall efficiency. Integration of IV equipment with healthcare information technology (IT) systems is becoming more prevalent. This includes connectivity with EHRs, allowing for seamless data exchange, better documentation, and improved coordination of care among healthcare providers. There has been a gradual shift toward disposable IV products, including IV catheters and tubing. Disposable items reduce the risk of infection and contribute to the overall safety of IV therapy. Healthcare facilities are increasingly adopting single-use products to enhance infection control measures. The rise of telemedicine has led to an increased focus on remote consultations. IV equipment that can be remotely monitored and adjusted is becoming more relevant, allowing healthcare providers to make real-time decisions even when patients are not physically present in healthcare facilities.
In terms of product the market is categorise into IV Catheters, Infusion Pumps, Administration Sets, Securement devices, Needless Connectors, Stopcocks and Check Valves, Drip Chambers and Others. IV catheters are widely used in a range of medical procedures, including routine hospital admissions, surgical interventions, emergency care, and outpatient treatments. Their versatile applications make them a fundamental component of intravenous therapy. IV catheters are a standard component in routine healthcare practices, and they are commonly used for the administration of fluids, medications, blood products, and nutrition. The frequency of these routine procedures contributes to the consistent demand for IV catheters. IV catheters come in various types, sizes, and materials to suit different patient needs and medical contexts. This diversity allows healthcare providers to select the most appropriate catheter for specific treatments, enhancing patient comfort and safety. In addition based on end user, there has been a significant rise in the provision of healthcare services in home settings. This is driven by factors such as the aging population, a preference for in-home care, and the desire to reduce healthcare costs. IV equipment designed for home use, including infusion pumps and accessories, plays a crucial role in supporting home healthcare services. Many patients prefer receiving treatments, including intravenous therapies, in the comfort of their own homes. Home care settings offer a more familiar and comfortable environment for patients, potentially improving treatment adherence and overall patient satisfaction. Furthermore, Cardiovascular disorders, including conditions such as heart failure, myocardial infarction, and arrhythmias, are prevalent in the United States. These conditions often require intravenous treatments for medication administration, fluid management, and other therapeutic interventions. Hypertension (high blood pressure) is a widespread health concern in the United States. Patients with hypertension may require intravenous medications for rapid and effective blood pressure control, contributing to the demand for IV equipment. Acute cardiac conditions, such as acute coronary syndrome and heart failure exacerbations, often necessitate the administration of intravenous medications for prompt intervention. IV equipment is crucial in delivering these medications in a controlled and efficient manner.
Considered in this report:
• Geography: United States
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028
Aspects covered in this report:
• United States IV Equipments market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
By Product:
• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others
By End User:
• Hospital
• Clinics
• Home Care Settings
• Others
By Indication:
• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.
Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the IV Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.